The Division of Medicinal Chemistry and Natural Products focuses on finding new therapeutic agents and targets. Thousands of compounds researched by the School have the potential for therapeutic applications impacting many disease targets, such as enzymes, specific drug receptors, and even genetics.
The division has been targeted for sustained growth, and recent developments in facilities, endowment and faculty additions make this an especially opportune time to join the division.
Stephen Frye, PhD, former worldwide head of discovery medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill. MORE
Betsy Sleath, PhD, an associate professor at the UNC School of Pharmacy, has received a three-year appointment to the Food and Drug Administration Risk Communication Advisory Committee.
Betsy Sleath, PhD, an associate professor at the UNC School of Pharmacy, has received a three-year appointment to the Food and Drug Administration Risk Communication Advisory Committee.
Betsy Sleath, PhD, an associate professor at the UNC School of Pharmacy, has received a three-year appointment to the Food and Drug Administration Risk Communication Advisory Committee.